IRVINE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and ...
IRVINE, Calif., Dec. 6, 2018 /PRNewswire/ -- Inari Medical, Inc. announced today the enrollment of the first patient in the FlowTriever All-Comer Registry for Patient Safety and Hemodynamics ("FLASH") ...
The FDA announced 510(k) clearance for Inari Medical’s FlowTriever device for the treatment of pulmonary embolism (“PE”). According to Inari, the FlowTriever system is the first thrombectomy device ...
Please provide your email address to receive an email when new articles are posted on . Two new thrombectomy devices showed good safety and efficacy in the treatment of intermediate-risk pulmonary ...
IRVINE, Calif., May 22, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous ...
IRVINE, Calif., Oct. 24, 2017 /PRNewswire/ -- Inari Medical, Inc., a privately held venture backed medical device company dedicated to the development of innovative catheter-based technologies for the ...
Inari Medical, Inc. NARI recently announced the commercial launch of two new purpose-built products, the RevCore thrombectomy catheter and the Triever16 Curve catheter. RevCore is currently the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results